Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-17-000500
Filing Date
2017-10-06
Accepted
2017-10-06 10:59:59
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJON M. SAKODAJOSHUA MAKOWERNEA 15 GP, LLCNEA PARTNERS 15, L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 15, L.P. - NIGHTSTAR THERAPEUTICS PLC 13D nightstar13d_18118.htm SC 13D 390833
  Complete submission text file 0001072613-17-000500.txt   392823
Mailing Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 15, L.P. (Filed by) CIK: 0001629794 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421
Business Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421 646-522-8445
Nightstar Therapeutics plc (Subject) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90131 | Film No.: 171126077
SIC: 2836 Biological Products, (No Diagnostic Substances)